{"name":"Merrion Pharmaceuticals, LLC","slug":"merrion-pharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOM0xkWVp1Mnd5bUlOMHBNSWhsbHZMcnJMQXoyMnBZbVltS0dyMVpMc1lsbEdGcmZNSTM1UHVBLXNTN2tFRUhRa2lSNjU4UnlROG1mRDV2bWJVcEdKdFpHMm1ReWxoWnBTZ1JnaFh3TThOWUNNTHJEM2VFdUYzWHRUVXB3WEFleWdial9uYnJEem9oOWExbmN5VTY3VndXTHktN2tvZmk2clNEMU1MN0dOQ0p3?oc=5","date":"2012-01-15","type":"pipeline","source":"The ASCO Post","summary":"Estrogen for Vulvovaginal Atrophy in Breast Cancer: Debate Continues - The ASCO Post","headline":"Estrogen for Vulvovaginal Atrophy in Breast Cancer: Debate Continues","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}